Ηλίας Θώδης Καθηγητής Νεφρολογίας ΔΠΘ

e-mail: ithodis@med.duth.gr 
1973:Απολυτήριο Γυμνασίου Θετικής Κατεύθυνσης, Καρδίτσας
1980:  Πτυχίο Ιατρικής Σχολής Αριστοτέλειου Πανεπιστημίου Θεσσαλονίκης 1988:Ειδικότητα 
ΕΣΩΤΕΡΙΚΗΣ ΠΑΘΟΛΟΓΙΑΣ

1990:Διδακτορική Διατριβή Τμήματος Ιατρικής Δημοκρίτειου Πανεπιστήμιου Θράκης Βαθμός: Άριστα

1993:  Ειδικότητα ΝΕΦΡΟΛΟΓΙΑΣ
10/1997–4/1998:Research Fellow in Division of Nephrology-Continuous Ambulatory Peritoneal Dialysis Unit–                    Stone Clinic – Osteoporosis Clinic Toronto Western Hospital, Toronto, Ontario, Canada

9/2000 – 12/2000:Research Fellow in Geriatric Nephrology Department in    University Health Network, Toronto General Hospital, Princess Margaret Hospital.
Υποτροφίες: Scholarship from the International Society for Peritoneal Dialysis to study “ CAPD-
Renal  Osteodystrophy - Osteoporosis” under Prof. 
D.G.Oreopoulos(Τoronto Western Division)

Επαγγελματική απασχόληση

1982-1985                               Στρατιωτική θητεία ως έφεδρος ανθυπολοχαγός

1980-1982                               Υπηρεσία υπαίθρου – (20 μήνες)

Αρριανά Σαπών νομού Ροδόπης

1982-1983                               Εξωτερικός Βοηθός Κρατικής Παθολογικής

Κλινικής Γενικού Κρατικού Νοσοκομείου

Αλεξανδρούπολης (Γ.Κ.Ν.Α.)

1985-1988                               Ειδίκευση στην Εσωτερική Παθολογία

Ιατρική Σχολή Δημοκρίτειου Πανεπιστήμιου Θράκης (Δ.Π.Θ.) – Εκπαίδευση στην Εξωνεφρική Κάθαρση

Μονάδα Τεχνητού Νεφρού – (Γ.Π.Ν.Α.)

                                   

1988 - 1993                             Επιμελητής Β’ Παθολογίας ΕΣΥ –

Κλινική δραστηριότητα στην Πανεπιστημιακή

Νεφρολογική Κλινική Δ.Π.Θ. και τη Μονάδα Τεχνητού Νεφρού – (Γ.Κ.Ν.Α.)

1993 - 1998                             Λέκτορας Νεφρολογίας Τμήματος Ιατρικής

Δημοκρίτειου Πανεπιστημίου Θράκης (Δ.Π.Θ.)

1998                                        Επίκουρος Καθηγητής Νεφρολογίας   Τμήματος Ιατρικής Δ.Π.Θ.

1997-78:                                  Research Fellow in Division of Nephrology-

                                                Toronto Western Hospital, Toronto, Ontario, Canada

1998                                        Reviewer στο περιοδικό Peritoneal Dialysis

International  (Journal of International Society for Peritoneal Dialysis) MULTIMED INC. Toronto, Canada.

2004-2010                               Αναπληρωτής Καθηγητής Νεφρολογίας                                    

                                                Τμήματος Ιατρικής  Δ.Π.Θ.

2010 έως σήμερα                    Καθηγητής Νεφρολογίας                                    

                                                Τμήματος Ιατρικής  Δ.Π.Θ.

ΔΗΜΟΣΙΕΥΣΕΙΣ ΣΕ ΔΙΕΘΝΗ ΠΕΡΙΟΔΙΚΑ

1: Fragidis S, Sombolos K, Thodis E, Panagoutsos S, Mourvati E, Pikilidou M,Papagianni A, Pasadakis P, Vargemezis V. Low T3 syndrome and long-term mortality in chronic hemodialysis patients. World J Nephrol. 2015 Jul 6;4(3):415-22. doi:10.5527/wjn.v4.i3.415. PubMed PMID: 26167466; PubMed Central PMCID: PMC4491933.

2: Georgiadis GS, Argyriou C, Antoniou GA, Kantartzi K, Kriki P, Theodoridis M, Thodis E, Lazarides MK. Upper limb vascular calcification score as a predictor of mortality in diabetic hemodialysis patients. J Vasc Surg. 2015 Jun;61(6):1529-37. doi: 10.1016/j.jvs.2015.01.026. Epub 2015 Feb 25. PubMed PMID: 25724616.

3: Tziakas D, Chalikias G, Stakos D, Altun A, Sivri N, Yetkin E, Gur M, Stankovic G, Mehmedbegovic Z, Voudris V, Chatzikyriakou S, Garcia-Moll X, Serra A, Passadakis P, Thodis E, Vargemezis V, Kaski JC, Konstantinides S. Validation of a new risk score to predict contrast-induced nephropathy after percutaneous coronary intervention. Am J Cardiol. 2014 May 1;113(9):1487-93. doi:10.1016/j.amjcard.2014.02.004. Epub 2014 Feb 12. PubMed PMID: 24630389.

4: Mitsopoulos E, Ginikopoulou E, Economidou D, Zanos S, Pateinakis P, Minasidis E, Memmos D, Thodis E, Vargemezis V, Tsakiris D. Impact of long-term cinacalcet, ibandronate or teriparatide therapy on bone mineral density of hemodialysis patients: a pilot study. Am J Nephrol.  012;36(3):238-44. Epub 2012 Aug 31. PubMed PMID: 22948280.

5: Vagiona A, Koupidis S, Passadakis P, Thodis E, Vargemezis V. Twenty four-hour

ambulatory blood pressure monitoring and lipid levels before, 3, 6 and 12 months

after the onset of hemodialysis in chronic kidney disease patients: a pilot

study. Hippokratia. 2012 Apr;16(2):154-8. PubMed PMID: 23935271; PubMed Central

PMCID: PMC3738417.

6: Tziakas D, Chalikias G, Stakos D, Apostolakis S, Adina T, Kikas P, Alexoudis A, Passadakis P, Thodis E, Vargemezis V, Konstantinides S. Development of an easily applicable risk score model for contrast-induced nephropathy prediction after percutaneous coronary intervention: a novel approach tailored to current practice. Int J Cardiol. 2013 Feb 10;163(1):46-55. doi: 10.1016 / j.ijcard. 2011. 05. 079. PubMed PMID: 21641061.

7: Thodis ED, Oreopoulos DG. Home dialysis first: a new paradigm for new ESRD patients. J ephrol. 2011 Jul-Aug;24(4):398-404. doi: 10.5301/JN.2011.8374. Review. PubMed PMID: 21623574.

8: Theodoridis M, Tziakas D, Passadakis P, Kantartzi K, Roumeliotis A, Thodis E, Vargemezis V. The effect of bicarbonate peritoneal dialysis solutions on cardiac structural and functional alterations. Nephrol Dial Transplant. 2011 Dec;26(12):4061-7. doi: 10.1093/ndt/gfr206. Epub 2011 May 4. PubMed PMID: 21543656.

9: Kakagia D, Kriki P, Thodis E, Roumeliotis A, Vargemezis V. Calcific uremic arteriolopathy treated with cinacalcet, paricalcitol, and autologous growth factors. J Cutan Med Surg. 2011 Mar-Apr;15(2):121-4. PubMed PMID: 21477562.

10: Theodoridis M, Thodis E, Tsigalou C, Pappi R, Roumeliotis A, Georgoulidou A, Passadakis P, Vargemezis V. Alterations of dialysate markers in chronic peritoneal dialysis patients treated with the new less bioincompatible bicarbonate solutions. Perit Dial Int. 2011 Mar-Apr;31(2):196-9. doi:

10.3747/pdi.2009.00139. PubMed PMID: 21427248.

11: Devetzis V, Passadakis P, Panagoutsos S, Theodoridis M, Thodis E,Georgoulidou A, Vargemezis V. Metformin-related lactic acidosis in patients withacute kidney injury. Int Urol Nephrol. 2011 Dec;43(4):1243-8. doi: 10.1007/s11255-010-9845-1. Epub 2010 Sep 22. PubMed PMID: 20859683.

12: Bacharaki D, Thodis E, Passadakis P, Kantartzi K, Kriki P, Vargemezis V.Comparative in vitro study of different peritoneal dialysis solutions on cytokine production by peripheral blood mononuclear cells. Nephron Clin Pract. 2009;113(4):c321-9. doi: 10.1159/000235951. Epub 2009 Sep 3. PubMed PMID: 19729968.

13: Thodis E, Kriki P, Kakagia D, Passadakis P, Theodoridis M, Mourvati E,Vargemezis V. Rigorous Vibrio vulnificus soft tissue infection of the lower leg in a renal transplant patient managed by vacuum therapy and autologous growth factors. J Cutan Med Surg. 2009 Jul-Aug;13(4):209-14. PubMed PMID: 19706229.

14: Vargemezis V, Liakopoulos V, Kriki P, Panagoutsos S, Leontsini M, Passadakis P, Thodis E. Pivotal role of paricalcitol in the treatment of calcific uremic arteriolopathy in the presence of a parathyroid adenoma. Am J Kidney Dis. 2010 Jan;55(1):144-7. doi: 10.1053/j.ajkd.2009.03.015. Epub 2009 May 29. PubMed PMID: 19481317.

15: Kriki P, Thodis E, Deftereos S, Panagoutsos S, Theodoridis M, Kantartzi K, Mourvati E, Prassopoulos P, Passadakis P, Vargemezis V. A tumor-like manifestation of extrapulmonary tuberculosis in a hemodialysis patient. Clin Nephrol. 2009 Jun;71(6):714-8. PubMed PMID: 19473642. 

16: Oreopoulos DG, Thodis E, Passadakis P, Vargemezis V. Home dialysis as a first option: a new paradigm. Int Urol Nephrol. 2009;41(3):595-605. doi: 10.1007/s11255-009-9575-4. Epub 2009 May 9. Review. PubMed PMID: 19430923.

17: Oreopoulos DG, Ossareh S, Thodis E. Peritoneal dialysis: past, present, and future. Iran J Kidney Dis. 2008 Oct;2(4):171-82. Review. PubMed PMID: 19377234.

18: Courcoutsakis N, Souftas V, Thodis I, Vargemezis V, Prassopoulos P. Sclerosing peritonitis. Intern Med. 2008;47(15):1441-2. Epub 2008 Aug 1. PubMed PMID: 18670153.

19: Aspris AK, Thodi CD, Balatsouras DG, Thodis ED, Vargemezis V, Danielides V. Auditory brainstem responses in patients under treatment of hemodialysis. Ren Fail. 2008;30(4):383-90. doi: 10.1080/08860220801947405. PubMed PMID: 18569911.

20: Oreopoulos D, Thodis E, Paraskevas KI. The promising future of long-term peritoneal dialysis. Int Urol Nephrol. 2008;40(2):405-10. doi:10.1007/s11255-008-9370-7. PubMed PMID: 18368504.

21: Theodoridis M, Passadakis P, Kriki P, Gioka T, Panagoutsos S, Mourvati E, Thodis E, Kantartzi K, Vargemezis V. The alteration of dialysate cancer antigen 125 concentration under a biocompatible bicarbonate peritoneal dialysis solution and the preservation of the mesothelial cell viability. Ren Fail. 2008;30(2):161-7. doi: 10.1080/08860220701808384. PubMed PMID: 18300115.

22: Ossareh S, Moupas I, Thodis E, Oreopoulos DG, Donnelly S. Correlation between fractional reabsorption of sodium and erythropoietin dose in peritoneal dialysis patients. Perit Dial Int. 2006 Sep-Oct;26(5):581-6. PubMed PMID: 16973514.

23: Thodi C, Thodis E, Danielides V, Pasadakis P, Vargemezis V. Hearing in renal failure. Nephrol Dial Transplant. 2006 Nov;21(11):3023-30. Epub 2006 Aug 25. Review. PubMed PMID: 16935898.

24: Griveas I, Visvardis G, Sakellariou G, Passadakis P, Thodis I, Vargemezis V, Pavlitou A, Fleva A. Biocompatibility study based on differential sequestration  kinetics of CD14+CD16+ blood monocyte subsets with different dialyzers. Ren Fail. 2006;28(6):493-9. PubMed PMID: 16928619.

25: Panagoutsos S, Kantartzi K, Passadakis P, Yannatos E, Mourvati E, Theodoridis M, Kriki P, Thodis E, Vargemezis V. Timely transfer of peritoneal dialysis patients to hemodialysis improves survival rates. Clin Nephrol. 2006 Jan;65(1):43-7. PubMed PMID: 16429841.

26: Mimidis K, Mourvati E, Kaliontzidou M, Papadopoulos V, Thodis E, Kartalis G, Vargemezis V. Efficacy of polyethylene glycol in constipated CAPD patients. Perit Dial Int. 2005 Nov-Dec;25(6):601-3.  PubMed PMID: 16411529.

27: Thodis E, Passadakis P, Lyrantzopooulos N, Panagoutsos S, Vargemezis V,

Oreopoulos D. Peritoneal catheters and related infections. Int Urol Nephrol.

2005;37(2):379-93. Review. PubMed PMID: 16142574.

28: Thodis E, Rossos P, Habal F, Oreopoulos D. Negative impact of Crohn's disease on bone mineral mass. J Musculoskelet Neuronal Interact. 2003 Sep;3(3):246-50. Erratum in: J Musculoskelet Neuronal Interact. 2003 Dec;3(4):442. PubMed PMID:15758348.

29: Thodis E, Passadakis P, Ossareh S, Panagoutsos S, Vargemezis V, Oreopoulos DG. Peritoneal catheter exit-site infections: predisposing factors, prevention and treatment. Int J Artif Organs. 2003 Aug;26(8):698-714. Review. PubMed PMID: 14521167.

30: Krishnan M, Thodis E, Ikonomopoulos D, Vidgen E, Chu M, Bargman JM, Vas SI, Oreopoulos DG. Predictors of outcome following bacterial peritonitis in peritoneal dialysis. Perit Dial Int. 2002 Sep-Oct;22(5):573-81. PubMed PMID: 12455568.

31: Malliara M, Passadakis P, Panagoutsos S, Theodoridis M, Thodis E, Bargman J, Jassal V, Vas S, Vargemezis V, Oreopoulos D. Hypotension in patients on chronic peritoneal dialysis: etiology, management, and outcome. Adv Perit Dial. 2002;18:49-54. PubMed PMID: 12402586.

32: Fytili CI, Progia EG, Panagoutsos SA, Thodis ED, Passadakis PS, Sombolos KI, Vargemezis VA. Lipoprotein abnormalities in hemodialysis and continuous ambulatory peritoneal dialysis patients. Ren Fail. 2002 Sep;24(5):623-30. PubMed PMID: 12380908. 

33: Panagoutsos SA, Yannatos EV, Passadakis PS, Thodis ED, Galtsidopoulos OG, Vargemezis VA. Effects of hemodialysis dose on anemia, hypertension, and nutrition. Ren Fail. 2002 Sep;24(5):615-21. PubMed PMID: 12380907. 

34: Passadakis P, Malliara M, Thodis E, Vargemezis V, Oreopoulos DG. Arterial hypotension in patients on peritoneal dialysis. Int J Artif Organs. 2002 Jun;25(6):489-95. PubMed PMID: 12117286.

35: Stathoulopoulou F, Dhillon S, Thodis H, Stathakis C, Vargemezis V. Evaluatio n of valaciclovir dosage reduction in continuous ambulatory peritoneal dialysis patients. Nephron. 2002 May;91(1):164-6. PubMed PMID: 12021536.

36: Thodis E, Passadakis P, Vargemezis V, Oreopoulos DG. Prevention of catheter related infections in patients on CAPD. Int J Artif Organs. 2001 Oct;24(10):671-82. Review. PubMed PMID: 11817317.

37: Passadakis P, Thodis E, Vargemezis V, Oreopoulos D. Long-term survival with peritoneal dialysis in ESRD due to diabetes. Clin Nephrol. 2001 Oct;56(4):257-70.Review. PubMed PMID: 11680655.

38: Vargemezis V, Thodis E. Prevention and management of peritonitis and exit-site infection in patients on continuous ambulatory peritoneal dialysis.Nephrol Dial Transplant. 2001;16 Suppl 6:106-8. Review. PubMed PMID: 11568263.

39: Thodis E, Passadakis P, Vargemezis V, Oreopoulos DG. Peritoneal dialysis:better than, equal to, or worse than hemodialysis? Data worth knowing before choosing a dialysis modality. Perit Dial Int. 2001 Jan-Feb;21(1):25-35. Review. PubMed PMID: 11280493.

40: Thodis E, Passadakis P, Panagoutsos S, Bacharaki D, Euthimiadou A, Vargemezis V. The effectiveness of mupirocin preventing Staphylococcus aureus in catheter-related infections in peritoneal dialysis. Adv Perit Dial. 2000;16:257-61. PubMed PMID: 11045306.

41: Passadakis P, Thodis E, Vargemezis V, Oreopoulos D. Long-term survival on peritoneal dialysis in end-stage renal disease owing to diabetes. Adv Perit Dial. 2000;16:59-66. PubMed PMID: 11045263.

42: Passadakis PS, Thodis ED, Panagoutsos SA, Selisiou CA, Pitta EM, Vargemezis VA. Outcome for continuous ambulatory peritoneal dialysis patients is not predicted by peritoneal permeability characteristics. Adv Perit Dial.2000;16:2-6. PubMed PMID: 11045251.

43: Passadakis P, Thodis E, Vargemezis V, Oreopoulos D. Abysmal prognosis with type 2 diabetes entering dialysis. Nephrol Dial Transplant. 2000 Aug;15(8):1257-8. PubMed PMID: 10910461.

44: Bhaskaran S, Schaubel DE, Jassal SV, Thodis E, Singhal MK, Bargman JM, Vas SI, Oreopoulos DG. The effect of small solute clearances on survival of anuric peritoneal dialysis patients. Perit Dial Int. 2000 Mar-Apr;20(2):181-7. PubMed PMID: 10809241.

45: Thodis E, Passadakis P, Panagoutsos S, Marinopoulos D, Vargemezis V. Failure of icodextrin to provide adequate ultrafiltration in continuous ambulatory peritoneal dialysis patients. Adv Perit Dial. 1999;15:171-4. PubMed PMID:10682096.

46: Passadakis P, Sud K, Dutta A, Singhal M, Pettit J, Chatalalsingh C, Thodis E, Vargemezis V, Oreopoulos D. Bioelectrical impedance analysis in the evaluation of the nutritional status of continuous ambulatory peritoneal dialysis patients. Adv Perit Dial. 1999;15:147-52. PubMed PMID: 10682091.

47: Euthimiadou A, Thodis E, Passadakis P, Tsalikis D, Kaisas G, Vargemezis V.Nonsurgical implantation of Tenckhoff peritoneal catheters in patients on continuous ambulatory peritoneal dialysis. Adv Perit Dial. 1999;15:101-4. PubMed PMID: 10682081.

48: Passadakis P, Panagoutsos S, Thodis E, Tsivara I, Sopassi F, Kartali S, Vargemezis V. Evaluation of changes in serum and dialysate levels of cancer antigen 125 in stable continuous ambulatory peritoneal dialysis patients. Adv Perit Dial. 1999;15:40-4. PubMed PMID: 10682070.

49: Passadakis P, Thodis E, Vargemezis V, Oreopoulos G. Recommendations for glucose control in diabetics on CAPD. Int J Artif Organs. 1999 Oct;22(10):657-64. Review. PubMed PMID: 10585128.

50: Passadakis P, Thodis E, Vargemezis V, Oreopoulos DG. Nutrition in diabetic patients undergoing continuous ambulatory peritoneal dialysis. Perit Dial Int. 1999;19 Suppl 2:S248-54. Review. PubMed PMID: 10406528.

51: Thodis E, Vas SI, Bargman JM, Singhal M, Chu M, Oreopoulos DG. Nystatin prophylaxis: its inability to prevent fungal peritonitis in patients on continuous ambulatory peritoneal dialysis. Perit Dial Int. 1998 Nov-Dec;18(6):583-9. PubMed PMID: 9932656. 

52: Thodis E, Vas S, Bargman JM, Oreopoulos DG. Early peritoneal catheter removal may be life saving in fungal peritonitis. Int J Artif Organs. 1998 Aug;21(8):489. PubMed PMID: 9803352.

53: Thodis E, Bhaskaran S, Pasadakis P, Bargman JM, Vas SI, Oreopoulos DG. Decrease in Staphylococcus aureus exit-site infections and peritonitis in CAPD patients by local application of mupirocin ointment at the catheter exit site. Perit Dial Int. 1998 May-Jun;18(3):261-70. PubMed PMID: 9663889.

54: Thodis ED, Oreopoulos DG. Refractory severe nocturia: its treatment with intranasal esmopressin. Geriatr Nephrol Urol. 1998;8(1):59-61. PubMed PMID:9650048.

55: Pasadakis P, Thodis E, Mourvati E, Euthimiadou A, Margaritis D, Manavis J, Vargemezis V. Evaluation of bone mineral density in CAPD patients with dual energy X-ray absorptiometry. Adv Perit Dial. 1996;12:245-9. PubMed PMID: 8865913.

56: Pasadakis P, Thodis E, Manavis J, Mourvati E, Panagoutsos S, Vargemezis V. The identification of bone mineral density in CAPD in comparison with HD patients. Adv Perit Dial. 1995;11:247-53. PubMed PMID: 8534716. 

57: Pasadakis P, Thodis E, Eftimimiadou A, Panagoutsos S, Papazoglou D, Kaliengidou M, Kartali S, Vargemezis V. Treatment and prevention of relapses of CAPD Pseudomonas peritonitis. Adv Perit Dial. 1993;9:206-10. PubMed PMID: 8105925.

58: Pasadakis P, Thodis E, Euthimiadou A, Panagoutsos S, Oustoglou E, Kartali S, Vargemezis V. Treatment of CAPD peritonitis with clavulanate potentiated ticarcillin. Adv Perit Dial. 1992;8:238-41. PubMed PMID: 1361796.

59: Thodis E, Anninos PA, Pasadakis P, Adamopoulos AV, Panagoutsos S, Vargemezis V. Evaluation of CNS-function in CAPD patients using magnetoencephalography (MEG): comparison with hemodialysis patients. Adv Perit Dial. 1992;8:181-4. PubMed PMID: 1361782.

60: Vargemezis V, Thodis E, Pasadakis P, Martinis G, Kousta E. Efficacy of vancomycin plus tobramycin as antiperitonitis regimen for patients on CAPD. Adv Perit Dial. 1990;6:123-5. PubMed PMID: 1982788. 

61: Vargemezis V, Pasadakis P, Thodis E. Effect of a calcium antagonist (verapamil) on the permeability of the peritoneal membrane in patients on continuous ambulatory peritoneal dialysis. Blood Purif. 1989;7(6):309-13. PubMed PMID: 2611001.

62: Vargemezis V, Pasadakis P, Thodis E. The effect of calcium antagonists on the peritoneal  membrane in patients on CAPD. Adv Perit Dial. 1989;5:8-11. PubMed PMID: 2577433.

63: Vargemezis V, Pasadakis P, Thodis H, Coucudis P, Peihaberis P, Jafer H, Jara F, Kartali S. Vancomycin therapy for gram-positive peritonitis in patients on CAPD. Adv Perit Dial. 1989;5:128-9. PubMed PMID: 2577394.